APA (7th ed.) Citation

SA, C. C., L, W., R, C., AV, A. M., A, R. S., MBV, S., . . . AJ, P. (2022). Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): A phase 4, non-inferiority, single blind, randomised study. Lancet (London, England), 399(10324), 521. https://doi.org/10.1016/S0140-6736(22)00094-0

Chicago Style (17th ed.) Citation

SA, Costa Clemens, et al. "Heterologous Versus Homologous COVID-19 Booster Vaccination in Previous Recipients of Two Doses of CoronaVac COVID-19 Vaccine in Brazil (RHH-001): A Phase 4, Non-inferiority, Single Blind, Randomised Study." Lancet (London, England) 399, no. 10324 (2022): 521. https://doi.org/10.1016/S0140-6736(22)00094-0.

MLA (9th ed.) Citation

SA, Costa Clemens, et al. "Heterologous Versus Homologous COVID-19 Booster Vaccination in Previous Recipients of Two Doses of CoronaVac COVID-19 Vaccine in Brazil (RHH-001): A Phase 4, Non-inferiority, Single Blind, Randomised Study." Lancet (London, England), vol. 399, no. 10324, 2022, p. 521, https://doi.org/10.1016/S0140-6736(22)00094-0.